CB2 Receptor Involvement in the Treatment of Substance Use Disorders
The pharmacological modulation of the cannabinoid receptor 2 (CB2r) has emerged as a promising potential therapeutic option in addiction. The purpose of this review was to determine the functional involvement of CB2r in the effects produced by drugs of abuse at the central nervous system (CNS) level...
Main Authors: | Francisco Navarrete, María S. García-Gutiérrez, Ani Gasparyan, Daniela Navarro, Jorge Manzanares |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/11/1556 |
Similar Items
-
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
by: Francisco Navarrete, et al.
Published: (2021-05-01) -
Sex Differences in Substance Use Disorders: A Neurobiological Perspective
by: Jennifer L. Cornish, et al.
Published: (2021-12-01) -
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
by: Amaya Austrich-Olivares, et al.
Published: (2022-04-01) -
Substance Use Disorder and COVID-19; Forensic Medicine and Pharmacology Perspectives: A Concise Narrative Review
by: Ahmed Ali, et al.
Published: (2021-12-01) -
Pharmacological blockade of either, cannabinoid CB1 or CB2 receptors, prevents both cocaine-induced conditioned locomotion and cocaine-induced reduction of cell proliferation in the hippocampus of adult male rats.
by: EDUARDO eBLANCO-CALVO, et al.
Published: (2014-01-01)